MPG.eBooks - Search Results

1

Drug class review on newer antiplatelet agents : final report update 1

by Dailey, Janet H.
Published 2007

Oregon Health & Science University, Evidence-Based Practice Center

Subjects: “...Platelet Aggregation Inhibitors / therapeutic use...”

Read Now

2

Drug class review on newer antiplatelet agents : final report update 1

by Dailey, Janet H.
Published 2007

Oregon Health & Science University, Evidence-Based Practice Center

Subjects: “...Platelet Aggregation Inhibitors / therapeutic use...”

Read Now

3

Dual antiplatelet therapy following percutaneous coronary intervention: A review of the clinical impact of treatment duration

by Wells, George A.
Published 2017

CADTH

Subjects: “...Platelet Aggregation Inhibitors / adverse effects...”

Read Now

4

Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration : recommendations

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Platelet Aggregation Inhibitors / adverse effects...”

Read Now

5

Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration

by Wells, George A.
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Platelet Aggregation Inhibitors / adverse effects...”

Read Now

6

Dual antiplatelet therapy following percutaneous coronary intervention: A review of the clinical impact of treatment duration

by Wells, George A.
Published 2017

CADTH

Subjects: “...Platelet Aggregation Inhibitors / adverse effects...”

Read Now

7

Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration

by Wells, George A.
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Platelet Aggregation Inhibitors / adverse effects...”

Read Now

8

Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration : recommendations

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Platelet Aggregation Inhibitors / adverse effects...”

Read Now

9

Drug class review: Newer antiplatelet agents : final update 2 report

by Ketchum, Kathy
Published 2011

Oregon Health & Science University

Subjects: “...Platelet Aggregation Inhibitors...”

Read Now

10

Drug class review: Newer antiplatelet agents : final update 2 report

by Ketchum, Kathy
Published 2011

Oregon Health & Science University

Subjects: “...Platelet Aggregation Inhibitors...”

Read Now

11

Management of antiplatelet therapy among patients on antiplatelet therapy for coronary or cerebrovascular disease or with prior percutaneous cardiac interventions undergoing electi...

by Shekelle, Paul G.
Published 2017

Department of Veterans Affairs, Health Services Research & Development Service

Subjects: “...Platelet Aggregation Inhibitors / adverse effects...”

Read Now

12

Management of antiplatelet therapy among patients on antiplatelet therapy for cerebrovascular or peripheral vascular diseases undergoing elective non-cardiac surgery

by Shekelle, Paul G.
Published 2017

Department of Veterans Affairs, Health Services Research & Development Service

Subjects: “...Platelet Aggregation Inhibitors / adverse effects...”

Read Now

13

Dual antiplatelet therapy acetylsalicylic acid dosing : a review of the clinical effectiveness and harms

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Platelet Aggregation Inhibitors / therapeutic use...”

Read Now

14

Dual antiplatelet therapy acetylsalicylic acid dosing : a review of the clinical effectiveness and harms

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Platelet Aggregation Inhibitors / therapeutic use...”

Read Now

15

Testing of CYP2C19 variants and platelet reactivity for guiding antiplatelet treatment

by Dahabreh, Issa J.
Published 2013

Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services

Subjects: “...Platelet Aggregation Inhibitors / therapeutic use...”

Read Now

16

Clopidogrel and proton pump inhibitor use : a review of the evidence on safety

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Platelet Aggregation Inhibitors / therapeutic use...”

Read Now

17

Clopidogrel and proton pump inhibitor use : a review of the evidence on safety

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Platelet Aggregation Inhibitors / therapeutic use...”

Read Now

18

Testing of CYP2C19 variants and platelet reactivity for guiding antiplatelet treatment

by Dahabreh, Issa J.
Published 2013

Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services

Subjects: “...Platelet Aggregation Inhibitors / therapeutic use...”

Read Now

19

Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration : project protocol

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Platelet Aggregation Inhibitors / administration & dosage...”

Read Now

20

Unstable angina and NSTEMI : the early management of unstable angina and non-ST-segment-elevation myocardial infarction

Published 2010

Royal College of Physicians

Subjects: “...Platelet Aggregation Inhibitors / therapeutic use...”

Narrow Search